Meta-analysis finds screening for prostate cancer with PSA does not reduce prostate cancer-related or all-cause mortality but results likely due to heterogeneity - the two highest quality studies identified do find prostate cancer-related mortality reductions

Evid Based Med. 2011 Feb;16(1):20-1. doi: 10.1136/ebm1165. Epub 2011 Jan 12.
No abstract available

Publication types

  • Comment